The global genomics market was valued at US$ 28.1 billion in 2022 and is projected to reach US$ 40.9 billion by 2030, growing at a CAGR of 13.4% from 2023-2030. The global genomics market refers to the market for technologies, products, and services related to the study and analysis of genetic information, including DNA sequencing, genotyping, gene expression analysis, and bioinformatics. This market is driven by advances in genomics research, personalized medicine, and increasing demand for precision medicine.

Browse 213 market data Tables and 94 Figures spread through 313 Pages and in-depth TOC on "Genomics Market Size, Share & Trends Estimation Report By Outlook, By Region, And Segment Forecasts, 2022 - 2030" View detailed Table of Content here-https://www.contrivedatuminsights.com/product-report/genomics-market-248622/

Advances in genomic technologies have resulted in increased efficiency and accuracy of genetic analysis, and reduced costs, driving demand for genomics products and services. Genomics research is enabling the development of personalized medicine, which tailors treatments to individual patients based on their genetic makeup. This has resulted in increased demand for genomic testing and analysis.

Market Dynamics

The high cost of genomic technologies and associated products and services can make them inaccessible to many individuals and healthcare providers, limiting their adoption and use. The use and storage of genomic data raises concerns about data privacy and security. These concerns could limit the adoption of genomic technologies and reduce the demand for genomic testing and analysis.

The use and storage of genomic data raises concerns about data privacy and security. These concerns could limit the adoption of genomic technologies and reduce the demand for genomic testing and analysis. The use of genomic data raises ethical concerns around issues such as genetic discrimination, informed consent, and ownership of genetic information, which could limit the adoption and growth of genomic technologies.

Genomic sequencing is a key technology in the genomics market, allowing researchers and clinicians to study the DNA sequence of individuals, populations, and species. The market for sequencing technologies is expected to continue to grow, driven by the increasing demand for personalized medicine, precision agriculture, and conservation genomics.

Precision medicine, which uses genomic data to tailor treatments to individual patients, is expected to drive demand for genomic testing and analysis in the healthcare industry. The growing adoption of precision medicine presents significant opportunities for companies offering genomics products and services. Emerging markets, such as China, India, and Brazil, represent significant growth opportunities for the genomics market. These markets have large populations with increasing demand for personalized medicine, creating opportunities for companies to expand their products and services into these regions.

Genomic microarrays are tools that allow researchers to analyze the expression of genes in a sample. The microarray market is expected to continue to grow, driven by the increasing demand for diagnostic and research applications in fields such as oncology, infectious diseases, and pharmacogenomics.

PCR is a technique used to amplify DNA segments for further analysis. The PCR market is expected to continue to grow, driven by the increasing demand for diagnostic and research applications in fields such as infectious diseases, oncology, and genetic disorders.

Genomics companies offer a wide range of products, including sequencing systems, microarrays, PCR machines, and gene editing tools. The product segment is expected to continue to dominate the genomics market, driven by the increasing demand for genomic technologies in research and clinical applications.

Regional Analysis

Genomics companies also offer a range of services, including sequencing services, data analysis, and bioinformatics. The service segment is expected to continue to grow, driven by the increasing demand for specialized services in fields such as precision medicine, oncology, and synthetic biology.

Europe is the second-largest market for genomics products and services, driven by increasing investments in genomics research and growing demand for personalized medicine. The United Kingdom, Germany, and France are the largest contributors to the European genomics market.

The Asia-Pacific region is expected to grow at the fastest rate in the genomics market due to increasing investments in genomics research, rising demand for personalized medicine, and increasing government support for genomics research. China, India, and Japan are the largest contributors to the Asia-Pacific genomics market. Latin America is a growing market for genomics products and services, driven by factors such as increasing investments in genomics research, growing demand for personalized medicine, and increasing awareness about genetic testing and analysis. Brazil and Mexico are the largest contributors to the Latin American genomics market.

Competitive Analysis

Some of the key players in the genomics market include Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., BGI Group, F. Hoffmann-La Roche AG, and Eurofins Scientific. The market is highly competitive, with many established players and new entrants constantly entering the market with innovative products and services.

In September 2020, Illumina, Inc. announced the acquisition of GRAIL, Inc., a company focused on developing blood tests for early cancer detection, for $8 billion. The acquisition is expected to strengthen Illumina's position in the cancer diagnostics market.

In March 2020, Thermo Fisher Scientific, Inc. announced the acquisition of Qiagen N.V., a provider of sample and assay technologies for genomics research and molecular diagnostics, for $11.5 billion. The acquisition is expected to enhance Thermo Fisher Scientific's position in the genomics market.

In December 2020, PerkinElmer, Inc. announced the acquisition of Oxford Immunotec, a provider of immunology-based diagnostic tests, for $591 million. The acquisition is expected to expand PerkinElmer's diagnostics portfolio.

In August 2020, Illumina, Inc. announced an investment in Luminostics, a company developing rapid diagnostic tests based on its smartphone-powered technology. The investment is expected to expand Illumina's portfolio of diagnostic products.

In June 2020, BGI Group announced the opening of a genomics research center in Copenhagen, Denmark. The new center is expected to expand BGI Group's presence in Europe and enhance its genomics research capabilities.

Segmentation Analysis of The Global Genomics Market 2016-2030

The report forecasts revenue growth at global, regional, and country matrics and analyzes the latest industry trends in each of the sub-segments ranging from 2016-2030. For this, CDI has segmented the global genomics market report based on capacity, vehicle, application, and propulsion type along with regional analysis. 

Application & Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Functional Genomics
• Transfection
• Real-Time PCR
• RNA Interference
• Mutational Analysis
• SNP Analysis
• Microarray Analysis
• Epigenomics
• Bisulfite Sequencing
• Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
• Methylated DNA Immunoprecipitation (MeDIP)
• High-Resolution Melt (HRM)
• Chromatin Accessibility Assays
• Microarray Analysis
• Pathway Analysis
• Bead-Based Analysis
• Microarray Analysis
• Real-time PCR

Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)

• Biomarker Discovery
• Mass Spectrometry
• Real-time PCR
• Microarray Analysis
• Statistical Analysis
• Bioinformatics
• DNA Sequencing
• Others

Deliverables Outlook (Revenue, USD Billion, 2018 - 2030)

Products

• Instruments/Systems/Software
• Consumables & Reagents

Services

• NGS-based Services
• Core Genomics Services
• Biomarker Translation Services
• Computational Services
• Others

End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Clinical Research
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America